Project title: Acquisition of a high-resolution scanning and production instrument set for the production of precision prototypes Project identification number: GINOP-PLUS-1.2.3-21-2022-02520 Duration of the project: 01.04.2022 – 30.10.2022. In addition to Anthelos products specializing in nucleic acid detection, the company is working on the development and introduction of new immunochemical technology. With the investment realized...

Anthelos widened its chemical portfolio with AK Scientific Inc. (Union City, California, USA) (www.aksci.com) after taking over the Hungarian distibutorship from Avidin (www.avidinbiotech.com) in June, 2021. AKSci provides high quality Inhibitors, Modulators, Ligands, Bioactives, and Reference Compounds for life science research, drug discovery, and many other research & development needs. Novel Building Blocks, Intermediates, and...

Anthelos has developed a novel molecular diagnostic product, the Microbiome genomic analysis kit (Cat. no. Ant-08) enabling semiquantitative detection of bacteria and fungi from diverse biological and environmental samples. The kit includes well designed primer sets that amplify 2 bacterial and 2 fungal genomic regions. The amplified products can be further analyzed by cloning, traditional...

Anthelos is proud to anounce that from January 2021 the company became the local distributor of TargetMol company (www.targetmol.com) in Hungary. With the expertise of Anthelos chemists we offer full support for our customers from both the academic and biotech sectors. Anthelos arranges shipment, customs clearance and all administration with fast delivery of the ordered...

Within the first few weeks after Anthelos foundation, our team of specialists validated a real-time Reverse Transcriptase PCR (QPCR) assay for the specific detection of the SARS-CoV-2 virus using saliva, sputum and nasal swabs. We used our know-how to establish the Inf-Cov2QuantTM Influenza A/B + SARS-CoV-2 Quantification Kit (ICQ-100), which is a multiplex molecular in vitro...